[{"Assets_0_Q3_USD":40278000.0,"CommonStockSharesOutstanding_0_Q3_shares":34852000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-14017000.0,"NetIncomeLoss_1_Q3_USD":-5407000.0,"NetIncomeLoss_3_Q3_USD":-17573000.0,"StockholdersEquity_0_Q3_USD":16737000.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]